HEADER RECEPTOR 13-OCT-03 1UPW TITLE CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING TITLE 2 DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST COMPND MOL_ID: 1; COMPND 2 MOLECULE: OXYSTEROLS RECEPTOR LXR-BETA; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LIGAND BINDING DOMAIN, RESIDUES 209-461; COMPND 5 SYNONYM: LIVER X RECEPTOR BETA, NUCLEAR ORPHAN, RECEPTOR LXR-BETA, COMPND 6 UBIQUITOUSLY-EXPRESSED NUCLEAR RECEPTOR, NUCLEAR RECEPTOR NER; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_PLASMID: PET28A(+) KEYWDS RECEPTOR, NUCLEAR HORMONE RECEPTOR, LIGAND BINDING DOMAIN, LIVER X KEYWDS 2 RECEPTOR, TRANSCRIPTION FACTOR EXPDTA X-RAY DIFFRACTION AUTHOR S.HOERER,A.SCHMID,A.HECKEL,R.M.BUDZINSKI,H.NAR REVDAT 3 28-MAR-18 1UPW 1 SOURCE REVDAT 2 24-FEB-09 1UPW 1 VERSN REVDAT 1 20-OCT-04 1UPW 0 JRNL AUTH S.HOERER,A.SCHMID,A.HECKEL,R.M.BUDZINSKI,H.NAR JRNL TITL CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA JRNL TITL 2 LIGAND-BINDING DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST JRNL REF J.MOL.BIOL. V. 334 853 2003 JRNL REFN ISSN 0022-2836 JRNL PMID 14643652 JRNL DOI 10.1016/J.JMB.2003.10.033 REMARK 2 REMARK 2 RESOLUTION. 2.40 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.1.19 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.40 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 87.6 REMARK 3 NUMBER OF REFLECTIONS : 10504 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.250 REMARK 3 FREE R VALUE : 0.295 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.800 REMARK 3 FREE R VALUE TEST SET COUNT : 527 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.40 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.46 REMARK 3 REFLECTION IN BIN (WORKING SET) : 772 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.2690 REMARK 3 BIN FREE R VALUE SET COUNT : 45 REMARK 3 BIN FREE R VALUE : 0.3700 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 1875 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 31 REMARK 3 SOLVENT ATOMS : 0 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 13.18 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 2.22000 REMARK 3 B22 (A**2) : -1.87000 REMARK 3 B33 (A**2) : -0.35000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.518 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.321 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.238 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 10.030 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.878 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.833 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1912 ; 0.012 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2589 ; 1.358 ; 1.959 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 230 ; 5.461 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): NULL ; NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 294 ; 0.095 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1447 ; 0.004 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 825 ; 0.218 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 30 ; 0.149 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 36 ; 0.261 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 7 ; 0.200 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1164 ; 0.574 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1880 ; 1.129 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 748 ; 1.873 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 709 ; 3.243 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 219 A 461 REMARK 3 ORIGIN FOR THE GROUP (A): 90.9938 -14.1682 19.7661 REMARK 3 T TENSOR REMARK 3 T11: 0.0638 T22: 0.1087 REMARK 3 T33: 0.1664 T12: 0.0172 REMARK 3 T13: 0.1026 T23: 0.0144 REMARK 3 L TENSOR REMARK 3 L11: 0.9628 L22: 1.0883 REMARK 3 L33: 3.7705 L12: 0.2183 REMARK 3 L13: -1.3316 L23: -0.8609 REMARK 3 S TENSOR REMARK 3 S11: 0.0930 S12: 0.1023 S13: 0.0167 REMARK 3 S21: -0.0122 S22: 0.0861 S23: 0.1953 REMARK 3 S31: -0.2553 S32: -0.1829 S33: -0.1791 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL PLUS MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1UPW COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 13-OCT-03. REMARK 100 THE DEPOSITION ID IS D_1290013703. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-OCT-02 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : 7.50 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9166 REMARK 200 MONOCHROMATOR : SI(111) MONOCHROMATOR REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 11049 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.400 REMARK 200 RESOLUTION RANGE LOW (A) : 89.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.9 REMARK 200 DATA REDUNDANCY : 2.800 REMARK 200 R MERGE (I) : 0.12100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 4.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.40 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.53 REMARK 200 COMPLETENESS FOR SHELL (%) : 92.4 REMARK 200 DATA REDUNDANCY IN SHELL : 2.80 REMARK 200 R MERGE FOR SHELL (I) : 0.39500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 1.700 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1FCY REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.60 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: RESERVOIR: 25% MPD, 10% PEG4K, 100 MM REMARK 280 HEPES PH 7.5, 10 MM D PROTEIN: 4-8 MG/ML IN 20 MM TRIS PH 8.0, REMARK 280 100 MM NACL, 10 MM, PH 7.50 REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 68.61000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.63800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 68.61000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 21.63800 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 FUNCTION: ORPHAN RECEPTOR. BINDS PREFERENTIALLY TO DOUBLE-STRANDED REMARK 400 OLIGONUCLEOTIDE DIRECT REPEATS HAVING THE CONSENSUS HALF-SITE REMARK 400 SEQUENCE 5'-AGGTCA-3' AND 4-NT SPACING (DR-4). REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 205 REMARK 465 SER A 206 REMARK 465 HIS A 207 REMARK 465 MET A 208 REMARK 465 SER A 209 REMARK 465 GLN A 210 REMARK 465 GLY A 211 REMARK 465 SER A 212 REMARK 465 GLY A 213 REMARK 465 GLU A 214 REMARK 465 GLY A 215 REMARK 465 GLU A 216 REMARK 465 GLY A 217 REMARK 465 VAL A 218 REMARK 465 CYS A 238 REMARK 465 ASN A 239 REMARK 465 LYS A 240 REMARK 465 ARG A 241 REMARK 465 SER A 242 REMARK 465 PHE A 243 REMARK 465 SER A 244 REMARK 465 ASP A 245 REMARK 465 GLN A 246 REMARK 465 PRO A 247 REMARK 465 LYS A 248 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLU A 225 CG CD OE1 OE2 REMARK 470 GLN A 237 CG CD OE1 NE2 REMARK 470 VAL A 249 CG1 CG2 REMARK 470 GLU A 461 CG CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 ASP A 257 CB - CG - OD2 ANGL. DEV. = 5.8 DEGREES REMARK 500 ASP A 338 CB - CG - OD2 ANGL. DEV. = 6.0 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 330 -98.26 -111.81 REMARK 500 LYS A 331 -45.02 -154.81 REMARK 500 ASP A 414 76.72 -105.51 REMARK 500 HIS A 460 139.99 43.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE 444 A1462 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1P8D RELATED DB: PDB REMARK 900 X-RAY CRYSTAL STRUCTURE OF LXR LIGAND BINDING DOMAIN WITH24(S),25- REMARK 900 EPOXYCHOLESTEROL REMARK 900 RELATED ID: 1PQ6 RELATED DB: PDB REMARK 900 HUMAN LXR BETA HORMONE RECEPTOR / GW3965 COMPLEX REMARK 900 RELATED ID: 1PQ9 RELATED DB: PDB REMARK 900 HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317COMPLEX REMARK 900 RELATED ID: 1PQC RELATED DB: PDB REMARK 900 HUMAN LXR BETA HORMONE RECEPTOR COMPLEXED WITH T0901317 REMARK 900 RELATED ID: 1UPV RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE HUMAN LIVER X RECEPTOR BETA LIGAND BINDING REMARK 900 DOMAIN IN COMPLEX WITH A SYNTHETIC AGONIST DBREF 1UPW A 205 208 PDB 1UPW 1UPW 205 208 DBREF 1UPW A 209 461 UNP P55055 NRH2_HUMAN 209 461 SEQRES 1 A 257 GLY SER HIS MET SER GLN GLY SER GLY GLU GLY GLU GLY SEQRES 2 A 257 VAL GLN LEU THR ALA ALA GLN GLU LEU MET ILE GLN GLN SEQRES 3 A 257 LEU VAL ALA ALA GLN LEU GLN CYS ASN LYS ARG SER PHE SEQRES 4 A 257 SER ASP GLN PRO LYS VAL THR PRO TRP PRO LEU GLY ALA SEQRES 5 A 257 ASP PRO GLN SER ARG ASP ALA ARG GLN GLN ARG PHE ALA SEQRES 6 A 257 HIS PHE THR GLU LEU ALA ILE ILE SER VAL GLN GLU ILE SEQRES 7 A 257 VAL ASP PHE ALA LYS GLN VAL PRO GLY PHE LEU GLN LEU SEQRES 8 A 257 GLY ARG GLU ASP GLN ILE ALA LEU LEU LYS ALA SER THR SEQRES 9 A 257 ILE GLU ILE MET LEU LEU GLU THR ALA ARG ARG TYR ASN SEQRES 10 A 257 HIS GLU THR GLU CYS ILE THR PHE LEU LYS ASP PHE THR SEQRES 11 A 257 TYR SER LYS ASP ASP PHE HIS ARG ALA GLY LEU GLN VAL SEQRES 12 A 257 GLU PHE ILE ASN PRO ILE PHE GLU PHE SER ARG ALA MET SEQRES 13 A 257 ARG ARG LEU GLY LEU ASP ASP ALA GLU TYR ALA LEU LEU SEQRES 14 A 257 ILE ALA ILE ASN ILE PHE SER ALA ASP ARG PRO ASN VAL SEQRES 15 A 257 GLN GLU PRO GLY ARG VAL GLU ALA LEU GLN GLN PRO TYR SEQRES 16 A 257 VAL GLU ALA LEU LEU SER TYR THR ARG ILE LYS ARG PRO SEQRES 17 A 257 GLN ASP GLN LEU ARG PHE PRO ARG MET LEU MET LYS LEU SEQRES 18 A 257 VAL SER LEU ARG THR LEU SER SER VAL HIS SER GLU GLN SEQRES 19 A 257 VAL PHE ALA LEU ARG LEU GLN ASP LYS LYS LEU PRO PRO SEQRES 20 A 257 LEU LEU SER GLU ILE TRP ASP VAL HIS GLU HET 444 A1462 31 HETNAM 444 N-(2,2,2-TRIFLUOROETHYL)-N-{4-[2,2,2-TRIFLUORO-1- HETNAM 2 444 HYDROXY-1-(TRIFLUOROMETHYL) HETNAM 3 444 ETHYL]PHENYL}BENZENESULFONAMIDE FORMUL 2 444 C17 H12 F9 N O3 S HELIX 1 1 THR A 221 GLN A 237 1 17 HELIX 2 2 SER A 260 LYS A 287 1 28 HELIX 3 3 GLY A 291 LEU A 295 5 5 HELIX 4 4 GLY A 296 ARG A 319 1 24 HELIX 5 5 SER A 336 ALA A 343 1 8 HELIX 6 6 GLN A 346 ARG A 361 1 16 HELIX 7 7 ARG A 362 GLY A 364 5 3 HELIX 8 8 ASP A 366 PHE A 379 1 14 HELIX 9 9 GLU A 388 ARG A 411 1 24 HELIX 10 10 LEU A 416 GLN A 445 1 30 HELIX 11 11 PRO A 450 ASP A 458 1 9 SHEET 1 AA 2 ILE A 327 THR A 328 0 SHEET 2 AA 2 THR A 334 TYR A 335 -1 O TYR A 335 N ILE A 327 SITE 1 AC1 14 PHE A 268 PHE A 271 LEU A 274 ALA A 275 SITE 2 AC1 14 MET A 312 LEU A 313 THR A 316 ILE A 327 SITE 3 AC1 14 LEU A 345 ILE A 353 HIS A 435 VAL A 439 SITE 4 AC1 14 LEU A 442 LEU A 449 CRYST1 137.220 43.276 51.615 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.007287 0.000000 0.000000 0.00000 SCALE2 0.000000 0.023107 0.000000 0.00000 SCALE3 0.000000 0.000000 0.019374 0.00000